{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:53:34Z","timestamp":1791615214089,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,30]]},"DOI":"10.7759\/cureus.48006","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:01:40Z","timestamp":1698710500000},"source":"Crossref","is-referenced-by-count":17,"title":["Retinitis Pigmentosa: Pathogenesis, Diagnostic Findings, and Treatment"],"prefix":"10.7759","author":[{"given":"Saakshi P","family":"Kamde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Anjankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Inherited retinal dystrophies- clinical profile & management","volume":"1","author":"Poornachandra B","year":"2022","unstructured":"Poornachandra B, Acharya I, Sangai S, Thomas S, Priya BV, Yadav NK. Inherited retinal dystrophies- clinical profile & management. J Vis Sci. 2022, 1:9-19.","journal-title":"J Vis Sci"},{"key":"ref2","article-title":"Genetics of eye diseases: an overview","author":"Kannabiran C","year":"2019","unstructured":"Kannabiran C. Genetics of eye diseases: an overview. Springer Nature (ed): Springer, Singapore; 2019."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000000690","article-title":"Retinitis pigmentosa: recent advances and future directions in diagnosis and management","volume":"30","author":"Fahim A","year":"2018","unstructured":"Fahim A. Retinitis pigmentosa: recent advances and future directions in diagnosis and management. Curr Opin Pediatr. 2018, 30:725-33. 10.1097\/MOP.0000000000000690","journal-title":"Curr Opin Pediatr"},{"key":"ref4","unstructured":"Retinitis Pigmentosa. (2022). Accessed. August 24, 2023: https:\/\/www.nei.nih.gov\/learn-about-eye-health\/eye-conditions-and-diseases\/retinitis-pigmentosa."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2174\/138920211795860107","article-title":"Retinitis pigmentosa: genes and disease mechanisms","volume":"12","author":"Ferrari S","year":"2011","unstructured":"Ferrari S, Di Iorio E, Barbaro V, Ponzin D, Sorrentino FS, Parmeggiani F. Retinitis pigmentosa: genes and disease mechanisms. Curr Genomics. 2011, 12:238-49. 10.2174\/138920211795860107","journal-title":"Curr Genomics"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.40.9.641","article-title":"The genetics of inherited macular dystrophies","volume":"40","author":"Michaelides M","year":"2003","unstructured":"Michaelides M, Hunt DM, Moore AT. The genetics of inherited macular dystrophies. J Med Genet. 2003, 40:641-50. 10.1136\/jmg.40.9.641","journal-title":"J Med Genet"},{"key":"ref7","unstructured":"Retinitis pigmentosa- encyclopedia, science news & research reviews. (2021). Accessed. August 24, 2023: https:\/\/academic-accelerator.com\/encyclopedia\/retinitis-pigmentosa."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1534\/genetics.111.136911","article-title":"Gene overexpression: uses, mechanisms, and interpretation","volume":"190","author":"Prelich G","year":"2012","unstructured":"Prelich G. Gene overexpression: uses, mechanisms, and interpretation. Genetics. 2012, 190:841-54. 10.1534\/genetics.111.136911","journal-title":"Genetics"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/genes10060453","article-title":"The cGMP pathway and inherited photoreceptor degeneration: targets, compounds, and biomarkers","volume":"10","author":"Tolone A","year":"2019","unstructured":"Tolone A, Belhadj S, Rentsch A, Schwede F, Paquet-Durand F.  The cGMP pathway and inherited photoreceptor degeneration: targets, compounds, and biomarkers. Genes (Basel). 2019, 10:10.3390\/genes10060453","journal-title":"Genes (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2015.06.007","article-title":"RPGR: Its role in photoreceptor physiology, human disease, and future therapies","volume":"138","author":"Megaw RD","year":"2015","unstructured":"Megaw RD, Soares DC, Wright AF. RPGR: Its role in photoreceptor physiology, human disease, and future therapies. Exp Eye Res. 2015, 138:32-41. 10.1016\/j.exer.2015.06.007","journal-title":"Exp Eye Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1517\/14728220903225016","article-title":"RPGR and RP2: targets for the treatment of X-linked retinitis pigmentosa?","volume":"13","author":"Veltel S","year":"2009","unstructured":"Veltel S, Wittinghofer A. RPGR and RP2: targets for the treatment of X-linked retinitis pigmentosa?. Expert Opin Ther Targets. 2009, 13:1239-51. 10.1517\/14728220903225016","journal-title":"Expert Opin Ther Targets"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2021.12.25","article-title":"In depth understanding of retinitis pigmentosa pathogenesis through optical coherence tomography angiography analysis: a narrative review","volume":"14","author":"Lu BW","year":"2021","unstructured":"Lu BW, Chao GJ, Wu GP, Xie LK. In depth understanding of retinitis pigmentosa pathogenesis through optical coherence tomography angiography analysis: a narrative review. Int J Ophthalmol. 2021, 14:1979-85. 10.18240\/ijo.2021.12.25","journal-title":"Int J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.80271","article-title":"Robust cone-mediated signaling persists late into rod photoreceptor degeneration","volume":"11","author":"Scalabrino ML","year":"2022","unstructured":"Scalabrino ML, Thapa M, Chew LA, et al.. Robust cone-mediated signaling persists late into rod photoreceptor degeneration. Elife. 2022, 11:10.7554\/eLife.80271","journal-title":"Elife"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14138","article-title":"Vascular dysfunction in retinitis pigmentosa","volume":"97","author":"Lang M","year":"2019","unstructured":"Lang M, Harris A, Ciulla TA, et al.. Vascular dysfunction in retinitis pigmentosa. Acta Ophthalmol. 2019, 97:660-4. 10.1111\/aos.14138","journal-title":"Acta Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.09.086","article-title":"Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection","volume":"59","author":"Kukreja RC","year":"2012","unstructured":"Kukreja RC, Salloum FN, Das A. Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection. J Am Coll Cardiol. 2012, 59:1921-7. 10.1016\/j.jacc.2011.09.086","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/11.10.1219","article-title":"Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns","volume":"11","author":"Rivolta C","year":"2002","unstructured":"Rivolta C, Sharon D, DeAngelis MM, Dryja TP. Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns. Hum Mol Genet. 2002, 11:1219-27. 10.1093\/hmg\/11.10.1219","journal-title":"Hum Mol Genet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.83608","article-title":"Retinitis pigmentosa: a brief overview","volume":"59","author":"Natarajan S","year":"2011","unstructured":"Natarajan S. Retinitis pigmentosa: a brief overview. Indian J Ophthalmol. 2011, 59:343-6. 10.4103\/0301-4738.83608","journal-title":"Indian J Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102656","article-title":"The new era of therapeutic strategies for the treatment of retinitis pigmentosa: A narrative review of pathomolecular mechanisms for the development of cell-based therapies","volume":"11","author":"Becherucci V","year":"2023","unstructured":"Becherucci V, Bacci GM, Marziali E, Sodi A, Bambi F, Caputo R. The new era of therapeutic strategies for the treatment of retinitis pigmentosa: A narrative review of pathomolecular mechanisms for the development of cell-based therapies. Biomedicines. 2023, 11:2656. 10.3390\/biomedicines11102656","journal-title":"Biomedicines"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12203","article-title":"Genes and mutations causing retinitis pigmentosa","volume":"84","author":"Daiger SP","year":"2013","unstructured":"Daiger SP, Sullivan LS, Bowne SJ. Genes and mutations causing retinitis pigmentosa. Clin Genet. 2013, 84:132-41. 10.1111\/cge.12203","journal-title":"Clin Genet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2717","article-title":"Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait","volume":"11","author":"Wright AF","year":"2010","unstructured":"Wright AF, Chakarova CF, Abd El-Aziz MM, Bhattacharya SS. Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait. Nat Rev Genet. 2010, 11:273-84. 10.1038\/nrg2717","journal-title":"Nat Rev Genet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0503460102","article-title":"RPE65 is the isomerohydrolase in the retinoid visual cycle","volume":"102","author":"Moiseyev G","year":"2005","unstructured":"Moiseyev G, Chen Y, Takahashi Y, Wu BX, Ma JX. RPE65 is the isomerohydrolase in the retinoid visual cycle. Proc Natl Acad Sci U S A. 2005, 102:12413-8. 10.1073\/pnas.0503460102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-7","article-title":"Cone rod dystrophies","volume":"2","author":"Hamel CP","year":"2007","unstructured":"Hamel CP. Cone rod dystrophies. Orphanet J Rare Dis. 2007, 2:7. 10.1186\/1750-1172-2-7","journal-title":"Orphanet J Rare Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0b013e3182474548","article-title":"Shedding light on photophobia","volume":"32","author":"Digre KB","year":"2012","unstructured":"Digre KB, Brennan KC. Shedding light on photophobia. J Neuroophthalmol. 2012, 32:68-81. 10.1097\/WNO.0b013e3182474548","journal-title":"J Neuroophthalmol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69740-7","article-title":"Retinitis pigmentosa","volume":"368","author":"Hartong DT","year":"2006","unstructured":"Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. The Lancet. 2006, 368:1795-1809. 10.1016\/S0140-6736(06)69740-7","journal-title":"The Lancet"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2009.176","article-title":"Relationship between peripheral visual field loss and vision-related quality of life in patients with retinitis pigmentosa","volume":"24","author":"Sugawara T","year":"2010","unstructured":"Sugawara T, Hagiwara A, Hiramatsu A, Ogata K, Mitamura Y, Yamamoto S. Relationship between peripheral visual field loss and vision-related quality of life in patients with retinitis pigmentosa. Eye (Lond). 2010, 24:535-9. 10.1038\/eye.2009.176","journal-title":"Eye (Lond)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2022-0057","article-title":"Clinical approach to vision loss: a review for general physicians","volume":"22","author":"Raharja A","year":"2022","unstructured":"Raharja A, Whitefield L. Clinical approach to vision loss: a review for general physicians. Clin Med (Lond). 2022, 22:95-9. 10.7861\/clinmed.2022-0057","journal-title":"Clin Med (Lond)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2007.05.003","article-title":"A novel cone visual cycle in the cone-dominated retina","volume":"85","author":"Muniz A","year":"2007","unstructured":"Muniz A, Villazana-Espinoza ET, Hatch AL, Trevino SG, Allen DM, Tsin AT. A novel cone visual cycle in the cone-dominated retina. Exp Eye Res. 2007, 85:175-84. 10.1016\/j.exer.2007.05.003","journal-title":"Exp Eye Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.11.029","article-title":"Clinical perspective: treating RPE65-associated retinal dystrophy","volume":"29","author":"Maguire AM","year":"2021","unstructured":"Maguire AM, Bennett J, Aleman EM, Leroy BP, Aleman TS. Clinical perspective: treating RPE65-associated retinal dystrophy. Mol Ther. 2021, 29:442-63. 10.1016\/j.ymthe.2020.11.029","journal-title":"Mol Ther"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2010.03.001","article-title":"Retinoids for treatment of retinal diseases","volume":"31","author":"Palczewski K","year":"2010","unstructured":"Palczewski K. Retinoids for treatment of retinal diseases. Trends Pharmacol Sci. 2010, 31:284-95. 10.1016\/j.tips.2010.03.001","journal-title":"Trends Pharmacol Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020685","article-title":"Retinitis Pigmentosa: novel therapeutic targets and drug development","volume":"15","author":"Wu KY","year":"2023","unstructured":"Wu KY, Kulbay M, Toameh D, Xu AQ, Kalevar A, Tran SD. Retinitis Pigmentosa: novel therapeutic targets and drug development. Pharmaceutics. 2023, 15:10.3390\/pharmaceutics15020685","journal-title":"Pharmaceutics"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017111","article-title":"Clinical characteristics and current therapies for inherited retinal degenerations","volume":"5","author":"Sahel JA","year":"2014","unstructured":"Sahel JA, Marazova K, Audo I. Clinical characteristics and current therapies for inherited retinal degenerations. Cold Spring Harb Perspect Med. 2014, 5:a017111. 10.1101\/cshperspect.a017111","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.06.041","article-title":"Gene therapy and stem cell transplantation in retinal disease: the new frontier","volume":"123","author":"MacLaren RE","year":"2016","unstructured":"MacLaren RE, Bennett J, Schwartz SD. Gene therapy and stem cell transplantation in retinal disease: the new frontier. Ophthalmology. 2016, 123:S98-S106. 10.1016\/j.ophtha.2016.06.041","journal-title":"Ophthalmology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/171391-retinitis-pigmentosa-pathogenesis-diagnostic-findings-and-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:09:14Z","timestamp":1707491354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/171391-retinitis-pigmentosa-pathogenesis-diagnostic-findings-and-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.48006","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,30]]}}}